glutathione peroxidase reaction 2 gsh h2o2 gssg 2 h2o Inhibition of GTRAP3-18 May Increase Neuroprotective (GSH) Synthesis Section 10.3. Oxygen , Cell

Description

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, dyslipidemia, obstructive sleep apnea or cardiovascular disease)

147:S80S87

Based on these findings, the authors concluded that assessment of liver enzymes could identify individuals at a high risk of incident T2D who may benefit from T2D prevention interventions